The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
| Image |  |
|---|---|
| Description | scientific article published in October 2002 |
| Author/s |
author: Thomas Kahan Lars Lind Pär Hallberg Fredrik H Nystrom Lisa Kurland |
| Publication date | October 1, 2002 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |